Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

New bradykinin B2 antagonist from Fujisawa

April 10, 1997

MT-5, a novel neuritogenic agent from Riken and Taisho

April 3, 1997

Inhibitors of IgE antibody production characterized by Teijin

April 3, 1997

Cationized AVP fragment for learning and memory disorders from Yakult

April 2, 1997

Sumitomo Metal characterizes new antiallergic/antiinflammatory agent

April 1, 1997

Nippon Shinyaku presents novel cerebroprotective agent

April 1, 1997

Novel 5-HT1A agonist described by Asahi Chemical

April 1, 1997

Kaken prepares broad-spectrum antiulcer agent

March 27, 1997

Antiplatelet 5-HT2A receptor antagonist characterized by Toa Eiyo

March 27, 1997

Armenian researchers describe novel antiarrhythmic agent

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...